Drug Type Small molecule drug |
Synonyms Magnesium Oxide/Riboflavin/Mecobalamin/Selenium In Dried Yeast/Pyridoxine Hydrochloride/Tocopherol Acetate Powder 50%/Gamma-Oryzanol, Alpha MG, 알파엠지정 |
Target |
Action stimulants, inhibitors |
Mechanism DNMT1 stimulants(DNA (cytosine-5)-methyltransferase 1 stimulants), Free radicals inhibitors, Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (28 Mar 2023), |
Regulation- |
Molecular FormulaC17H20N4O6 |
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N |
CAS Registry83-88-5 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Cheilitis | South Korea | 28 Mar 2023 | |
| Dermatitis | South Korea | 28 Mar 2023 | |
| Eczema | South Korea | 28 Mar 2023 | |
| Glossitis | South Korea | 28 Mar 2023 | |
| Menopausal symptoms | South Korea | 28 Mar 2023 | |
| Poor peripheral circulation | South Korea | 28 Mar 2023 | |
| Riboflavin Deficiency | South Korea | 28 Mar 2023 | |
| Stomatitis and ulceration | South Korea | 28 Mar 2023 | |
| Vitamin B 6 Deficiency | South Korea | 28 Mar 2023 | |
| Vitamin E Deficiency | South Korea | 28 Mar 2023 |





